Barclays PLC Vericel Corp Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Vericel Corp stock. As of the latest transaction made, Barclays PLC holds 110,046 shares of VCEL stock, worth $5.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,046
Previous 111,527
1.33%
Holding current value
$5.45 Million
Previous $4.71 Million
28.25%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$399 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$173 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$160 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$119 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$111 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.34B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...